Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

First-Time OTC Facility Inspections Drove US FDA Warning Letter Surge In FY 2019

Nov 06 2019

• By Joanne S. Eglovitch

Related Content

FDA Warning Letters Hit Three Repackers For Failing To Identify Original API Makers

Jul 03 2019

FDA Global Supply Chain Concerns Prompt Glycerin DEG Testing Guidance

May 07 2007

Warning Letters Mount As FDA Completes Initial Inspections Of Under-The-Radar Facilities

Jun 11 2018

Additional Topics

International United States OTC Drugs FDA Regulation Commercial Compliance Enforcement Manufacturing Policy Consumer

More from International

More from Geography

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window